This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial. Mike was one of the co-authors on this impressive publication and gives us insight into the study and its results. Very thought provoking!
You can get CME credit for this episode here! Click here for CME Account Creation Instructions
ICH accounts for approximately 15 percent of all strokes. Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50...
ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema. Is it safe? ...
Mechanically ventilating the patient with a severe asthma exacerbation is fraught with peril. Incorrect settings for tidal volume, respiratory rate, pressure triggers, or inspiratory...